This study is looking at a new way to use an advanced pneumatic compression device (APCD) to treat lower extremity lymphedema (swelling in the legs). Researchers want to see if a revised compression program works better than the current method to improve how your lymphatic system moves fluid. They will use Indocyanine Green (IC-Green) dye to measure changes in your lymphatic system. You may be able to join if you are 18 or older, have lower extremity lymphedema, and are a candidate for APCD treatment. The study is currently unclear on its recruitment status.

Study design

This is an interventional study with a planned enrollment of 5 participants. It compares a single session of the current APCD treatment with a single session using revised compression programming.

What's involved

You would have two in-clinic treatment sessions, each lasting 60 minutes. Indocyanine Green dye will be used to assess your lymphatic system before and after each treatment.

Compensation

Not stated in the trial record.

Follow-up

Lymphatic anatomy and propulsion will be measured before and after each 60-minute treatment session.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.